Marielle Konig-Schuster

Title: Marielle Konig-Schuster: Innovator in Antiviral Pharmaceutical Compositions

Introduction

Marielle Konig-Schuster is a notable inventor based in Austria. She has made significant contributions to the field of antiviral pharmaceutical compositions. Her work focuses on developing effective treatments for viral infections, particularly those affecting the eyes.

Latest Patents

Marielle has been involved in the development of innovative patents, including the "Iota-Carrageenan Composition Effective Against Viral Conjunctivitis." This invention relates to a pharmaceutical composition designed for the prophylactic or therapeutic treatment of viral eye infections caused by adenovirus subtype D or influenza A virus subtype H7. The composition features iota carrageenan as the active antiviral ingredient and is formulated to be substantially free of metal halide salts or contains no more than 0.5% w/v of such salts. Another significant patent is the "Synergistic Antiviral Composition And Use Thereof," which combines iota- and/or kappa-carrageenan with a neuraminidase inhibitor for treating symptoms associated with influenza virus infections.

Career Highlights

Marielle Konig-Schuster is currently associated with Marinomed Biotech AG, a company known for its innovative approaches in biotechnology. Her work at Marinomed has been pivotal in advancing antiviral treatments and enhancing the efficacy of existing medications.

Collaborations

Throughout her career, Marielle has collaborated with esteemed colleagues, including Andreas Grassauer and Eva Prieschl-Grassauer. These partnerships have fostered a collaborative environment that encourages innovation and the development of groundbreaking pharmaceutical solutions.

Conclusion

Marielle Konig-Schuster's contributions to antiviral pharmaceutical compositions highlight her dedication to improving healthcare outcomes. Her innovative patents and collaborations reflect her commitment to advancing medical science.